1. Home
  2. MFIN vs EOLS Comparison

MFIN vs EOLS Comparison

Compare MFIN & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Medallion Financial Corp.

MFIN

Medallion Financial Corp.

HOLD

Current Price

$9.48

Market Cap

240.7M

Sector

Finance

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$6.56

Market Cap

284.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MFIN
EOLS
Founded
1995
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
240.7M
284.3M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
MFIN
EOLS
Price
$9.48
$6.56
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$12.00
$15.50
AVG Volume (30 Days)
48.4K
919.8K
Earning Date
04-29-2026
05-04-2026
Dividend Yield
5.18%
N/A
EPS Growth
N/A
1.23
EPS
N/A
N/A
Revenue
N/A
$297,176,000.00
Revenue This Year
N/A
$13.27
Revenue Next Year
$0.02
$17.62
P/E Ratio
$6.21
N/A
Revenue Growth
N/A
11.61
52 Week Low
$7.85
$3.86
52 Week High
$11.00
$10.62

Technical Indicators

Market Signals
Indicator
MFIN
EOLS
Relative Strength Index (RSI) 55.15 72.95
Support Level $9.14 $6.44
Resistance Level $10.14 $7.29
Average True Range (ATR) 0.29 0.36
MACD 0.02 0.07
Stochastic Oscillator 72.63 87.80

Price Performance

Historical Comparison
MFIN
EOLS

About MFIN Medallion Financial Corp.

Medallion Financial Corp is a finance company that originates and services loans in various industries. The five operating segments are, (1) recreation, (2) home improvement, (3) commercial, (4) taxi medallion, and (5) strategic partnership loans. The company generates maximum revenue from the Recreation segment.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: